Research led by scientists at the University of British Columbia has uncovered the mechanism by which a specific genetic variant accelerates the onset of Huntington disease (HD), potentially by as much as 12.5 years. The study indicates that this variant drives significant DNA changes in the brain’s most vulnerable neurons, leading to a more aggressive progression of the disease.
Dr. Michael Hayden, a senior author of the study published in Neuron, stated that the findings provide compelling evidence that the repeated expansion of the mutation is a critical factor in HD pathology and may serve as a target for future therapies. The research highlights the importance of understanding the genetic underpinnings of HD, particularly how the CAG repeat expansion in the Huntingtin gene correlates with clinical manifestations of the disease.
Moreover, the study suggests that traditional blood tests may not accurately reflect the disease’s progression within the brain, indicating a need for more precise biomarkers in Huntington disease research. This insight could reshape clinical trial designs and therapeutic strategies aimed at mitigating the effects of this devastating neurological disorder.
Open the full market picture for your next decision →
